ES372359A1 - Amino-Acids containing Thioether Groups and their Derivatives - Google Patents
Amino-Acids containing Thioether Groups and their DerivativesInfo
- Publication number
- ES372359A1 ES372359A1 ES372359A ES372359A ES372359A1 ES 372359 A1 ES372359 A1 ES 372359A1 ES 372359 A ES372359 A ES 372359A ES 372359 A ES372359 A ES 372359A ES 372359 A1 ES372359 A1 ES 372359A1
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- alkoxy
- amino
- phenyl
- anilino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/56—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Manufacture And Refinement Of Metals (AREA)
Abstract
Pharmaceutical preparations useful in the treatment of inflammation contain as active ingredient compounds I (including optically active isomers and acid addition salts thereof and symmetrical anhydrides of comounds I in which R 2 is hydroxy) where n is 1, 2 or 3, R signifies H, halogen, SH, CN, C 1 _ 5 alkylsulphonyl, C 1 _ 5 alkylsulphinyl, C 1 _ 6 alkanoyl, trifluoroacetyl, C 1 _ 5 haloalkyl, SO 2 NH 2 , di(C 1 _ 5 alkyl), sulphamoyl, CONH 2 , di(C 1 _ 5 alkyl) carbamoyl, OH, C 1 _ 5 alkylthio, C 1 _ 5 alkoxy, anisyl, phenyl, NO 2 , phenethyl, C 1 _ 5 alkyl, methylenedioxy, anilino, N-(C 1 _ 5 alkyl) anilino, (C 1 _ 5 alkyl) phenyl, di(C 1 _ 5 alkyl) amino, cyclohexyl, iphenoxy, NH 2 , acylamino, C 1 _ 5 alkylamino or C 2 _ 5 alkenyl, R 2 signifies OH C 1 _ 5 alkoxy, C 2 _ 5 alkenyloxy, C 2 _ 5 alkynyloxy, cyclopropylmethyloxy, (C 1-5 alkoxy)-(C 1-5 alkoxy), poly (C 1-5 alkoxy)-(C 1-5 alkoxy), di(C 1-5 alkylamino)-(C 1-5 alkoxy), piperidino-(C 1-5 alkoxy), 1 pyrrolidinyl-(C 1-5 alkoxy), morpholino-(C 1-5 alkoxy), [1- (C 1-5 alkyl)-2-pyrrolidinyl]-[C 1-5 alkoxy], [-1-C 1-5 alkyl)-2-piperidinyl]-[C 1-5 alkoxy], N-(C 1-5 alkyl) -N-piperazinyl-(C 1-5 alkoxy), phenoxy, p-(C 1-6 alkanoyl) aminophenoxy, phenyl-(C 1-5 alkoxy) carhamoylphenoxy, (C 1-5, alkoxyphenyl)-(C 1-5 alkoxy), phenyl-(C 2-5 alkenyloxy), tetrahydrofurfuryloxy, di(C 1-5 alkyl) amino-cyclohexyloxy, NH 2 , C 1-5 alkylamino, di(C 1-5 alkyl) amino, glucosamino, glycosylamino, (C 2-5 alkenyl) amino, phenyl (C 1-5 alkyl) amino, haloanilino, [1-(C 1-5 alkyl) piperidinyl-2]-[C 1-5 alkyl] amino, tetrahydrofurfurylamino, 1, 2, 5, 6-tetrahydropyridino, morpholino, N'-(C 1-5 alkyl)-N-PiPerazinyl, piperazino, N-phenyl-piperazino, piperidino, benzylamino, anilino, (C 1-5 alkoxy) anilino, C 3-6 cycloalkylamino, pyrrolidino, N- (C 1-5 hydroxyalkyl)-piperazino, N,N-di(C 1-5 alkyl) carbamoyl-(C 1-5 alkyl)-amino, N,N-di (C 1-5 alkyl) amino-(C 1-5 alkyl) amino, [1-(C 1-5 alkyl) 1 pyrrolidino-2]-[C 1-5 alkylamino], N-carbobenzyloxy-C 1-5 alkyl) amino, or an OZ radical where Z is a cation, R 1 , R 3 and R 3 signify H, C 1-5 alkyl or phenyl, each of R 4 and R 5 is H, C 1-5 alkyl, C 1-6 alkanoyl or phenyl or R 4 is guanyl and R 5 is H, and R 6 and R 6 ' signify H, C 1-5 alkyl, C 2-5 alkenyl, phenyl, naphthyl, thienyl or pyridyl or substituted phenyl ornaphthyl wherein the substituents are (R) n . salicylates, e.g. aspirin, may also be incorporated into the preparations. Administration is, e.g. in the form of tablets, pills, powders, capsules, elixirs and injectable liquids.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65604167A | 1967-07-26 | 1967-07-26 | |
US72835168A | 1968-05-10 | 1968-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES372359A1 true ES372359A1 (en) | 1971-10-16 |
Family
ID=27097099
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES356488A Expired ES356488A1 (en) | 1967-07-26 | 1968-07-24 | Amino-Acids containing Thioether Groups and their Derivatives |
ES372358A Expired ES372358A1 (en) | 1967-07-26 | 1969-10-09 | Amino-Acids containing Thioether Groups and their Derivatives |
ES372359A Expired ES372359A1 (en) | 1967-07-26 | 1969-10-09 | Amino-Acids containing Thioether Groups and their Derivatives |
ES372357A Expired ES372357A1 (en) | 1967-07-26 | 1969-10-09 | Amino-Acids containing Thioether Groups and their Derivatives |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES356488A Expired ES356488A1 (en) | 1967-07-26 | 1968-07-24 | Amino-Acids containing Thioether Groups and their Derivatives |
ES372358A Expired ES372358A1 (en) | 1967-07-26 | 1969-10-09 | Amino-Acids containing Thioether Groups and their Derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES372357A Expired ES372357A1 (en) | 1967-07-26 | 1969-10-09 | Amino-Acids containing Thioether Groups and their Derivatives |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS5019543B1 (en) |
BE (1) | BE718559A (en) |
CH (1) | CH534138A (en) |
DE (1) | DE1768964A1 (en) |
ES (4) | ES356488A1 (en) |
FR (2) | FR1586146A (en) |
GB (1) | GB1191042A (en) |
IE (1) | IE32515B1 (en) |
IL (1) | IL30369A (en) |
NL (1) | NL144484B (en) |
NO (1) | NO124205B (en) |
SE (1) | SE364040B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE733993A (en) * | 1968-06-14 | 1969-12-03 | ||
US4315031A (en) * | 1977-09-01 | 1982-02-09 | Science Union Et Cie | Thiosubstituted amino acids |
FR2434149A1 (en) * | 1978-06-22 | 1980-03-21 | Parcor | NEW L-CYSTEIN DERIVATIVES |
US4246263A (en) * | 1979-10-15 | 1981-01-20 | Pfizer Inc. | Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions |
DE3303344A1 (en) * | 1983-02-02 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | METHOD FOR PRODUCING N-ALKYLATED AMINO ACIDS AND THEIR ESTERS |
DE10045831A1 (en) * | 2000-09-14 | 2002-04-04 | Gruenenthal Gmbh | Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site |
DK1317426T3 (en) | 2000-09-14 | 2006-01-09 | Gruenenthal Gmbh | Pay-thio-amino acids |
US9664138B2 (en) | 2010-12-29 | 2017-05-30 | Ford Global Technologies, Llc | Cylinder block |
-
1968
- 1968-07-11 NL NL686809834A patent/NL144484B/en not_active IP Right Cessation
- 1968-07-15 IL IL30369A patent/IL30369A/en unknown
- 1968-07-15 NO NO2800/68A patent/NO124205B/no unknown
- 1968-07-16 IE IE849/68A patent/IE32515B1/en unknown
- 1968-07-17 SE SE09792/68A patent/SE364040B/xx unknown
- 1968-07-18 DE DE19681768964 patent/DE1768964A1/en active Pending
- 1968-07-22 GB GB34780/68A patent/GB1191042A/en not_active Expired
- 1968-07-24 ES ES356488A patent/ES356488A1/en not_active Expired
- 1968-07-25 FR FR1586146D patent/FR1586146A/fr not_active Expired
- 1968-07-25 JP JP43052196A patent/JPS5019543B1/ja active Pending
- 1968-07-25 FR FR160545A patent/FR7960M/fr not_active Expired
- 1968-07-25 BE BE718559D patent/BE718559A/xx not_active Expired
- 1968-07-25 CH CH1113468A patent/CH534138A/en not_active IP Right Cessation
-
1969
- 1969-10-09 ES ES372358A patent/ES372358A1/en not_active Expired
- 1969-10-09 ES ES372359A patent/ES372359A1/en not_active Expired
- 1969-10-09 ES ES372357A patent/ES372357A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO124205B (en) | 1972-03-20 |
BE718559A (en) | 1969-01-27 |
IE32515B1 (en) | 1973-09-05 |
GB1191042A (en) | 1970-05-06 |
ES372357A1 (en) | 1972-01-16 |
FR1586146A (en) | 1970-02-13 |
NL144484B (en) | 1975-01-15 |
NL6809834A (en) | 1969-01-28 |
JPS5019543B1 (en) | 1975-07-08 |
IL30369A0 (en) | 1968-09-26 |
FR7960M (en) | 1970-06-01 |
SE364040B (en) | 1974-02-11 |
CH534138A (en) | 1973-02-28 |
ES372358A1 (en) | 1971-10-16 |
IL30369A (en) | 1973-08-29 |
DE1768964A1 (en) | 1972-01-27 |
IE32515L (en) | 1969-01-26 |
ES356488A1 (en) | 1970-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG17753A (en) | Novel pharmacological compounds | |
GB1277132A (en) | Pyridobenzo-diazepine derivatives | |
IL107426A0 (en) | Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
DK134185D0 (en) | ANTI-VIRAL ACTIVE PYRIDAZINAMINES | |
GR3004114T3 (en) | ||
DE69502130D1 (en) | Polyene derivatives, pharmaceutical and cosmetic compositions containing them and their use | |
ES372357A1 (en) | Amino-Acids containing Thioether Groups and their Derivatives | |
ZA885151B (en) | Novel substituted n-(3-hydroxy-4-piperidinyl)benzamides | |
GB8425104D0 (en) | Amide derivatives | |
ES8600309A1 (en) | Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them. | |
GB1322370A (en) | Hydroxycrotonic acid derivatives their preparation and compositions containing them and intermediates for the preparation of the same | |
SE7606424L (en) | SUBSTITUTED BENZAMIDS | |
DE69524781D1 (en) | PREPARATIONS OF 1,5-BENZODIAZEPINE DERIVATIVES WITH CCK ANTAGONISTIC OR AGONISTIC EFFECT WITH ENTERIC COATING | |
GB1076867A (en) | Improvements in or relating to 2,4-diamino-6-substituted pyrimidines | |
GB2204039B (en) | 2-amino-4-halogeno-6-cyclopropyl-1,3,5-triazines useful as intermediates for the production of herbicidally active n-(cyclopropyl-1,3,5-triazinyl)-n'-aryl-sul | |
GB1173701A (en) | 5-Substituted-1,4-Benzodiazepines |